Administration study for IGF-1 and somatropin to healthy Japanese adult females
Not Applicable
- Conditions
- ot applicable
- Registration Number
- JPRN-jRCT1080221643
- Lead Sponsor
- Mitsubishi Chemical Medience Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Female
- Target Recruitment
- 8
Inclusion Criteria
Weight: more than 40 kg, below 67.5kg BMI more than 17.6 and below 26.4
Exclusion Criteria
-Hypersensitivity to drugs,
-A history of alcoholism or drug addiction,
-Ethical or OTC pharmaceuticals administered within two weeks before scheduled administration of the study drug,
-Supplement, grapefruit or its products, or foods containing Hypericum perforatum
consumed within one week before scheduled administration of the study drug, and
- Not less than 200 mL of blood is collected within 30 days or not less than 400 mL of blood is collected within 90 days before scheduled administration of the study drug.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method